1. There seems to be a large misunderstanding regarding how medications and delivery devices go through FDA approval. So let me explain. To bring a drug to the market, the manufacturer uses a delivery device. Pulmozyme used various traditional nebs & compressors because that's what was on the market in the early 90s. There is no requirement for the manufacturer's of Pulmozyme to do tests for the eFlow. Pulmozyme is already FDA approved. The eFlow, on the same token, does not have to come to the market with a drug. It's simply a drug delivery device.
Here's another example. Albuterol came to the market prior to the traditional nebs/compressors we use today. But the traditional nebs/compressors that we use today didn't have to come to market being tested for albuterol. On the same token, the manufacturer of albuterol didn't have to conduct studies for the new nebs/compressors we use today.
2. Studies have been done, so smack your lawyer friend Jen. In fact, blood samples as well as sputum samples have been done using the eFlow comparing blood and sputum samples with traditional nebs (this is how dose efficacy is measured). So your lawyer friend is grossly misinformed. Colistin is studied and many use the eFlow with Colistin and Pulmozyme and we aren't dead. I would never decide to not use a med or delivery device based on a sensationalized story that I don't know the details of.
3. Using Tobramycin or Colistin is not "off label." Labels, aka what the FDA states in prescribing information, is for types of diseases the drug is indicated for. Switching a delivery device for a medication is not off label. In fact, if you're waiting for the FDA to get involved in approving drugs for the eFlow after the drugs have received approval to market (Pulmozyme, tobramycin, Colistin) you are going to be waiting in perpetuity. That is not how the FDA works.
So, as Jen said, <b> do you due dilligence </b> as opposed to listening to random stories people say and/or not reading published clinical studies.
If you wish to view the eFlow studies with Pulmozyme, tobramycin and colistin, visit my blow. Scroll down to the left and under categories, click "eFlow."
Skye, in terms of your use for EAP, I would stick with what they tell you because you're in a clinical trial. They are concerned about the proper cleaning and regulation of eFlow use. I don't think using the eFlow with other meds is a big deal, but for the integrity of the study, I would hold off.
Here's another example. Albuterol came to the market prior to the traditional nebs/compressors we use today. But the traditional nebs/compressors that we use today didn't have to come to market being tested for albuterol. On the same token, the manufacturer of albuterol didn't have to conduct studies for the new nebs/compressors we use today.
2. Studies have been done, so smack your lawyer friend Jen. In fact, blood samples as well as sputum samples have been done using the eFlow comparing blood and sputum samples with traditional nebs (this is how dose efficacy is measured). So your lawyer friend is grossly misinformed. Colistin is studied and many use the eFlow with Colistin and Pulmozyme and we aren't dead. I would never decide to not use a med or delivery device based on a sensationalized story that I don't know the details of.
3. Using Tobramycin or Colistin is not "off label." Labels, aka what the FDA states in prescribing information, is for types of diseases the drug is indicated for. Switching a delivery device for a medication is not off label. In fact, if you're waiting for the FDA to get involved in approving drugs for the eFlow after the drugs have received approval to market (Pulmozyme, tobramycin, Colistin) you are going to be waiting in perpetuity. That is not how the FDA works.
So, as Jen said, <b> do you due dilligence </b> as opposed to listening to random stories people say and/or not reading published clinical studies.
If you wish to view the eFlow studies with Pulmozyme, tobramycin and colistin, visit my blow. Scroll down to the left and under categories, click "eFlow."
Skye, in terms of your use for EAP, I would stick with what they tell you because you're in a clinical trial. They are concerned about the proper cleaning and regulation of eFlow use. I don't think using the eFlow with other meds is a big deal, but for the integrity of the study, I would hold off.